ARAlexander Rabinovich

Alexander Rabinovich

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexander Rabinovich has a total of 48 co-authors. Here are the top co-authors by number of shared publications:

  • Alexandra Papaioannou

    McMaster University, Hamilton, ON, Canada

    3 shared publications
  • George Ioannidis

    Affiliations Department of Medicine, McMaster University, Hamilton, Ontario, Canada, Department of Health Research Methods, Evidence and Impact (HEI), McMaster University, Hamilton, Ontario, Canada, Geras Centre for Aging Research, Hamilton Health Sciences, St. Peter’s Hospital, Hamilton, Ontario, Canada

    3 shared publications
  • Jonathan Adachi

    Affiliations Department of Medicine, McMaster University, Hamilton, Ontario, Canada, Geras Centre for Aging Research, Hamilton Health Sciences, St. Peter’s Hospital, Hamilton, Ontario, Canada

    3 shared publications
  • Lehana Thabane

    Affiliations Department of Health Research Methods, Evidence and Impact (HEI), McMaster University, Hamilton, Ontario, Canada, Geras Centre for Aging Research, Hamilton Health Sciences, St. Peter’s Hospital, Hamilton, Ontario, Canada, Biostatistics Unit, St Joseph’s Healthcare Hamilton, Hamilton, Ontario, Canada, Faculty of Health Sciences, University of Johannesburg, Johannesburg, South Africa

    3 shared publications
  • Patricia Hewston

    Affiliations Department of Medicine, McMaster University, Hamilton, Ontario, Canada, Geras Centre for Aging Research, Hamilton Health Sciences, St. Peter’s Hospital, Hamilton, Ontario, Canada, School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada

    3 shared publications
  • Alexa Kouroukis

    Affiliations Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

    2 shared publications

Latest Publications

  • Open Access

    Study protocol for a multiarm, randomized controlled trial to determine the effectiveness of community-based frailty rehabilitation to improve physical function in older adults: The OPTIMAL Fitness Trial

    by Alexandra Papaioannou, Courtney Kennedy, Justin Lee, Patricia Hewston, Caitlin McArthur, Shyam Maharaj, Jonathan Adachi, Pauline Boulos, Raja Bobba, Alexander Rabinovich, et al.

    Background: Frailty in older adults is on the rise with the rapid aging population. Frailty is dynamic and proven to be reversible or treatable. Evidence regarding the clinical effectiveness of community-based frailty interventions is limited. Frailty rehabilitation has the potential to be an accessible community-based intervention that may enable independence. We will examine a model of frailty rehabilitation and consider key components for improving physical function, frailty, sarcopenia, and cost-effectiveness. Methods: A multiarm, parallel-group, partially blinded, randomized controlled trial will compare the clinical and cost-effectiveness of OPTimizing Independence, Mobility, and Active Life (OPTIMAL) Fitness multimodal (group exercise, nutritional coaching/supplementation, medication optimization) versus OPTIMAL Fitness exercise-only and control. Participants in the OPTIMAL Fitness multimodal and exercise-only groups will attend exercise classes twice weekly for 4 months and be provided with a tailored one-hour home exercise program. We will recruit community-dwelling older adults living with frailty aged ≥65 years. Eligibility includes a FRAIL scale score of ≥2 (prefrail or frail), ability to ambulate 25 meters, follow two-step commands, and not attend another group exercise program. The target sample size is 324 participants (n = 108 per arm). The primary outcome is physical function measured via the Short Performance Physical Battery and the 400m Walk Test. Secondary outcomes include frailty change, sarcopenia, cognition, affect, quality of life, and healthcare utilization. Outcome analysis will be performed via generalized linear model analysis. Analyses will be based on the intention-to-treat principle. This protocol is guided by the Standard Protocol Items: Recommendations for Interventional Trials statement. Discussion: This trial is the first to determine whether a community-based frailty rehabilitation intervention can improve physical function in older adults with frailty and the level of intervention needed. The results from the OPTIMAL Fitness study will guide the development of a standardized program that could be implemented in global regions. Trial registration: ClinicalTrials.gov Identifier: NCT03824106 Registered January 31, 2019, https://www.clinicaltrials.gov/study/NCT03824106

  • Open Access

    The reliability and validity of a non-wearable indoor positioning system to assess mobility in older adults: A cross-sectional study

    by Isabel B. Rodrigues, Patricia Hewston, Jonathan Adachi, Sayem Borhan, George Ioannidis, Alexa Kouroukis, Carolyn Leckie, Andrea Lee, Alexander Rabinovich, Parthipan Siva, et al.

    Background: Detecting early changes in walking speed can allow older adults to seek preventative rehabilitation. Currently, there is a lack of consensus on which assessments to use to assess walking speed and how to continuously monitor walking speed outside of the clinic. Chirp is a privacy-preserving radar sensor developed to continuously monitor older adults’ safety and mobility without the need for cameras or wearable devices. Our study purpose was to evaluate the inter-sensor reliability, intrasession test-retest reliability, and concurrent validity of Chirp in a clinical setting. Methods: We recruited 35 community-dwelling older adults (mean age 75.5 (standard deviation: 6.6) years, 86% female). All participants lived alone in an urban city in southwestern Ontario and had access to a smart device with wireless internet. Data were collected with a 4-meter ProtoKinetics ZenoTM Walkway (pressure sensors) with the Chirp sensor (radar positioning) at the end of the walkway. We assessed participants walking speed during normal and adaptive locomotion experimental conditions (walking-while-talking, obstacle, narrow walking, fast walking). We selected walking speed as a measure as it is a good predictor of functional mobility but also is associated with physical and cognitive functioning in older adults. Each of the experimental conditions was conducted twice in a randomized order, with fast walking trials performed last. For intra-session reliability testing, we conducted two blocks of walks within a participant session separated by approximately 30 minutes. Intraclass Correlation Coefficient(A,1) (ICC(A,1)) was used to assess the reliability and validity. Linear regression, adjusted for gender, was used to investigate the association between Chirp and cognition and health-related quality of life scores. Results: Chirp walking speed inter-sensor reliability ICC(A,1) = 0.999[95% Confidence Interval [CI]: 0.997 to 0.999] and intrasession test-retest reliability [ICC(A,1) = 0.921, 95% CI: 0.725 to 0.969] were excellent across all experimental conditions. Chirp walking speed concurrent validity compared to the ProtoKinetics ZenoTM Walkway was excellent across experimental conditions [ICC(A,1) = 0.993, 95% CI: 0.985 to 0.997]. We found a weak association between walking speed and cognition scores using the Montreal Cognitive Assessment across experimental conditions (estimated β-value = 7.79, 95% CI: 2.79 to 12.80) and no association between walking speed and health-related quality of life using the 12-item Short Form Survey across experimental conditions (estimated β-value = 6.12, 95% CI: -7.12 to 19.36). Conclusion: Our results demonstrate that Chirp is a reliable and valid measure to assess walking speed parameters in clinics among older adults.

  • Open Access

    Intra-articular injection of a cross-linked hyaluronic acid combined with triamcinolone hexacetonide improves pain at six months in patients with mild to moderate hip osteoarthritis: A prospective observational study

    by Yoan Bourgeault-Gagnon, Nicole Simunovic, Diane Heels-Ansdell, Alexander Rabinovich, Eugene Maida, Ryan Williams, Shariff Dessouki, Andrew Duong, Justin Lautenbach, Stephen Kapuvari, et al.


  • Open Access

    The reliability and validity of a non-wearable indoor positioning system to assess mobility in older adults: A cross-sectional study

    by Isabel B. Rodrigues, Patricia Hewston, Jonathan Adachi, Sayem Borhan, George Ioannidis, Alexa Kouroukis, Carolyn Leckie, Andrea Lee, Alexander Rabinovich, Parthipan Siva, et al.

    Background: Chirp is a privacy-preserving radar sensor developed to continuously monitor older adults’ safety and mobility without the need for cameras or wearable devices. Our study purpose was to evaluate the inter-sensor reliability, intrasession test-retest reliability, and concurrent validity of Chirp in a clinical setting. Methods: We recruited 35 community-dwelling older adults (mean age 75.5 (standard deviation: 6.6) years, 86% female). All participants lived alone in an urban city in southwestern Ontario and had access to a smart device with wireless internet. Data were collected with a 4-meter ProtoKinetics Zeno™ Walkway (pressure sensors) with the Chirp sensor (radar positioning) at the end of the walkway. Participants walked during normal and adaptive locomotion experimental conditions (walking-while-talking, obstacle, narrow walking, fast walking). Each of the experimental conditions was conducted twice in a randomized order, with fast walking trials performed last. For intra-session reliability testing, we conducted two blocks of walks within a participant session separated by approximately 30 minutes. Intraclass Correlation Coefficient (A,1) (ICC (A,1) ) was used to assess the reliability and validity. Linear regression, adjusted for gender, was used to investigate the association between Chirp and cognition and health-related quality of life scores. Results: The Chirp inter-sensor reliability ICC (A,1) =0.999[95% Confidence Interval [CI]: 0.997 to 0.999] and intrasession test-retest reliability [ICC (A,1) =0.921, 95% CI: 0.725 to 0.969] were excellent across all experimental conditions. Chirp concurrent validity compared to the ProtoKinetics Zeno™ Walkway was excellent across experimental conditions [ICC (A,1) = 0.993, 95% CI: 0.985 to 0.997]. We found a weak association between Chirp and cognition scores using the Montreal Cognitive Assessment across experimental conditions (estimated β-value= 7.79, 95% CI: 2.79 to 12.80) and no association between the Chirp and health-related quality of life using the 12-item Short Form Survey across experimental conditions (estimated β-value=6.12, 95% CI: -7.12 to 19.36). Conclusion: Our results demonstrate that Chirp is a reliable and valid measure to assess gait parameters in clinics among older adults.